Selected publications
-
Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: A cohort study.
Breast Cancer Research.
2019
Academic Article
GET IT
Times cited: 4 -
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.
Nature Genetics.
2017
Academic Article
GET IT
Times cited: 62 -
Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women.
Breast Cancer Research.
2016
Academic Article
GET IT
Times cited: 12 -
Uterine cancer after risk-reducing salpingo-oophorectomy without hysterectomy in women with BRCA Mutations.
JAMA oncology.
2016
Academic Article
GET IT
Times cited: 71 -
Male breast cancer in BRCA1 and BRCA2 mutation carriers: Pathology data from the Consortium of Investigators of Modifiers of BRCA1/2.
Breast Cancer Research.
2016
Academic Article
GET IT
Times cited: 33 -
Assessing associations between the AURKAHMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers.
PLoS ONE.
2015
Academic Article
GET IT
Times cited: 11 -
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.
JAMA - Journal of the American Medical Association.
2015
Academic Article
GET IT
Times cited: 169 -
Breast cancer risk reduction, version 2.2015 clinical practice guidelines in oncology clinical practice guidelines in oncology.
JNCCN Journal of the National Comprehensive Cancer Network.
2015
Review
GET IT
Times cited: 21 -
Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers.
Breast Cancer Research.
2014
Academic Article
GET IT
Times cited: 23 -
DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.
PLoS Genetics.
2014
Academic Article
GET IT
Times cited: 22 -
Genetic/familial high-risk assessment: Breast and ovarian, version 1.2014.
JNCCN Journal of the National Comprehensive Cancer Network.
2014
Review
GET IT
Times cited: 77 -
Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk.
PLoS Genetics.
2013
Academic Article
GET IT
Times cited: 167 -
Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.
Cancer Epidemiology Biomarkers and Prevention.
2012
Academic Article
GET IT
Times cited: 33 -
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.
Breast Cancer Research.
2011
Academic Article
GET IT
Times cited: 48 -
Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers.
Human Genetics.
2011
Academic Article
GET IT
Times cited: 11 -
Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer.
PLoS Biology.
2011
Academic Article
GET IT
Times cited: 52 -
Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers.
Human Molecular Genetics.
2011
Academic Article
GET IT
Times cited: 54 -
Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers.
Journal of the National Cancer Institute.
2011
Academic Article
GET IT
Times cited: 31 -
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: Implications for risk prediction.
Cancer Research.
2010
Academic Article
GET IT
Times cited: 132 -
A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population.
Nature Genetics.
2010
Academic Article
GET IT
Times cited: 233 -
Breast cancer risk reduction.
JNCCN Journal of the National Comprehensive Cancer Network.
2010
Review
GET IT
Times cited: 22 -
Common genetic variants and modification of penetrance of BRCA2-associated breast cancer.
PLoS Genetics.
2010
Academic Article
GET IT
Times cited: 69 -
Genetic/familial high-risk assessment: Breast and ovarian - Clinical practice guidelines in oncology™.
JNCCN Journal of the National Comprehensive Cancer Network.
2010
Review
GET IT
Times cited: 163 -
Breast cancer screening and diagnosis: Clinical practice guidelines in oncology™.
JNCCN Journal of the National Comprehensive Cancer Network.
2009
Review
GET IT
Times cited: 221 -
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers.
Human Molecular Genetics.
2009
Academic Article
GET IT
Times cited: 88 -
Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: A multicenter, prospective study.
Journal of Clinical Oncology.
2008
Academic Article
GET IT
Times cited: 392 -
Breast cancer risk reduction: Clinical Practice Guidelines in Oncology™.
JNCCN Journal of the National Comprehensive Cancer Network.
2007
Conference Paper
GET IT
Times cited: 10 -
AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: A Consortium of Investigators of Modifiers of BRCA1/2 study.
Cancer Epidemiology Biomarkers and Prevention.
2007
Academic Article
GET IT
Times cited: 26 -
Genetic/familial high-risk assessment: Breast and ovarian. Clinical Practice Guidelines in Oncology™.
JNCCN Journal of the National Comprehensive Cancer Network.
2006
Conference Paper
GET IT
Times cited: 39 - Seminars in Breast Disease: Introduction. Seminars in Breast Disease. 2004 Conference Paper GET IT
-
Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium.
Proceedings of the National Academy of Sciences of the United States of America.
2002
Academic Article
GET IT
Times cited: 72 -
Participation in the cooperative family registry for breast cancer studies: Issues of informed consent.
Journal of the National Cancer Institute.
2000
Article
GET IT
Times cited: 11